This event has run. Thank you to our speakers, sponsors, and delegates who joined us for the 2026 summit.

Radiopharm Doses First Patient in Phase I Prostate Cancer Radiotherapy Study
Alpha‑Emitting PSMA Therapies Gain Momentum Across Radiopharma Leaders
Ratio Therapeutics Highlights the Next Wave of Radiopharmaceutical Manufacturing Standards
Radiopharma Veterans From Novartis‑Built Platforms Strengthen Emerging Biotechs
Radiopharma Takes Center Stage as Global Biopharma Partnering Accelerates

Using Quantitative Molecular Imaging to Strengthen Preclinical Radiopharmaceutical Development

Using Quantitative Molecular Imaging to Strengthen Preclinical Radiopharmaceutical Development

1:30 pm - Thursday 23rd July 2026

Applying advanced imaging technologies to evaluate target expression, pharmacokinetics and treatment response
Developing imaging biomarkers that improve confidence in preclinical efficacy and safety assessment
Generating robust translational evidence to support progression into early clinical development

Speakers:

Eric Ahrens

Professor

UC San Diego